Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Fixed drug eruption to erythromycin.

P D Pigatto, A Riboldi, F Riva

    Acta Dermato-Venereologica
    |January 1, 1984
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    The International Guideline for the Definition, Classification, Diagnosis and Management of Urticaria.

    Allergy·2026
    Same author

    Projectile deformation on human bone and on a polyurethane simulant.

    International journal of legal medicine·2025
    Same author

    Morphological and functional analysis of cryopreserved human sperm: comparison of different freezing protocols.

    Cryo letters·2025
    Same author

    The influence of a skin simulant on bullet trajectory deflection in ballistic gelatine.

    Forensic science international·2025
    Same author

    A narrative review on diagnosis and treatment of ifosfamide-induced encephalopathy, the perspective of a EURACAN reference center for sarcomas.

    Frontiers in pharmacology·2025
    Same author

    Radiological evaluation of response in patients with locally advanced/metastatic soft tissue sarcoma treated with trabectedin.

    Frontiers in pharmacology·2024
    Same journal

    Psychiatric Risk in Chronic Spontaneous Urticaria: A Retrospective Cohort Study.

    Acta dermato-venereologica·2026
    Same journal

    Erythematous Nodules and Plaques on the Neck: A Quiz.

    Acta dermato-venereologica·2026
    Same journal

    Dupilumab in Difficult-to-treat Chronic Spontaneous Urticaria: A Real-world Multicentre Cohort Study.

    Acta dermato-venereologica·2026
    Same journal

    Application of IL-17A Inhibitors in Psoriasis Complicated by Multiple Infections - Successful Treatment and Insights from a Case of Psoriasis with HIV and Neurosyphilis.

    Acta dermato-venereologica·2026
    Same journal

    A Systematic Literature Review on Methotrexate Hepatotoxicity in Psoriasis Management: Preconceived Notion or Real Threat?

    Acta dermato-venereologica·2026
    Same journal

    Standardizing Prurigo Control Assessment Globally: Linguistic Validation and Cross-cultural Adaptation of Prurigo Control Test in 18 Languages.

    Acta dermato-venereologica·2026
    See all related articles

    This case study details a patient experiencing recurrent allergic skin reactions specifically after taking erythromycin. It is the first documented instance linking erythromycin to this type of allergic eruption.

    Area of Science:

    • Pharmacology
    • Dermatology
    • Allergy and Immunology

    Background:

    • Erythromycin is a widely prescribed macrolide antibiotic used to treat various bacterial infections.
    • Adverse drug reactions, including allergic responses, can occur with any medication.
    • Identifying specific drug triggers for allergic reactions is crucial for patient safety.

    Observation:

    • A patient presented with a recurring skin eruption following the administration of erythromycin.
    • The eruption reappeared upon subsequent exposure to the antibiotic, suggesting a causal link.

    Findings:

    • This case represents the first documented evidence confirming erythromycin as the causative agent for this specific type of allergic skin reaction.
    • The repeated nature of the eruption strongly supports an allergic mechanism mediated by erythromycin.

    Related Experiment Videos

    Implications:

    • Clinicians should consider erythromycin as a potential trigger for similar allergic eruptions in patients with a relevant history.
    • This finding highlights the importance of thorough drug history and allergy assessments in clinical practice.
    • Further research may be warranted to understand the immunological mechanisms behind erythromycin-induced allergic reactions.